Announcements Trials

Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 3 Glioblastoma 2 Vulvar Neoplasms 1 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Oropharyngeal Neoplasms 1 Neoplastic Cells, Circulating 1 Neoplasm, Residual 1 Muscle Invasive Bladder Urothelial Carcinoma 1 Melanoma 1 Locally Advanced Rectal Carcinoma 1 Hypoxia 1 Gliosarcoma 1 Glioma 1 Genetic Diseases, Inborn 1 Esophageal Neoplasms 1 Circulating Tumor DNA 1 Carcinoma, Non-Small-Cell Lung 1 Biliary Tract Neoplasms 1 Astrocytoma 1

Interventions

Radiotherapy 10 Cisplatin 9 pembrolizumab 6 Surveys and Questionnaires 6 Methods 6 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 5 fludarabine 4 Papillomavirus Vaccines 4 Early Intervention, Educational 4 Cyclophosphamide 4 Brachytherapy 4 durvalumab 3 aldesleukin 3 Vaccines, Synthetic 3 Vaccines 3 Sentinel Lymph Node Biopsy 3 Radiosurgery 3 Radiation 3 Platinum 3 Palliative Care 3 Paclitaxel 3 Nivolumab 3 Indocyanine Green 3 Gemcitabine 3 Drug Therapy 3 Carboplatin 3 Bleomycin 3 Biopsy 3 1,2-diaminocyclohexaneplatinum II citrate 3 tremelimumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Vulvar Neoplasms × Circulating Tumor DNA × Clear all

NCT06582108 2024-09-03

ROAR

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Not yet recruiting

Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡